Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Statistics

Total Valuation

SNDX has a market cap or net worth of $1.12 billion. The enterprise value is $881.40 million.

Market Cap	1.12B
Enterprise Value	881.40M

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025, before market open.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

SNDX has 86.04 million shares outstanding. The number of shares has increased by 21.67% in one year.

Current Share Class	86.04M
Shares Outstanding	86.04M
Shares Change (YoY)	+21.67%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	100.08%
Float	76.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	47.01
Forward PS	11.53
PB Ratio	3.87
P/TBV Ratio	3.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	37.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.82, with a Debt / Equity ratio of 1.20.

Current Ratio	5.82
Quick Ratio	5.76
Debt / Equity	1.20
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-68.91

Financial Efficiency

Return on equity (ROE) is -75.69% and return on invested capital (ROIC) is -35.69%.

Return on Equity (ROE)	-75.69%
Return on Assets (ROA)	-31.74%
Return on Invested Capital (ROIC)	-35.69%
Return on Capital Employed (ROCE)	-54.67%
Revenue Per Employee	$87,704
Profits Per Employee	-$1.18M
Employee Count	270
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.93% in the last 52 weeks. The beta is 1.28, so SNDX's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	-37.93%
50-Day Moving Average	13.36
200-Day Moving Average	16.84
Relative Strength Index (RSI)	55.49
Average Volume (20 Days)	1,988,950

Short Selling Information

The latest short interest is 19.36 million, so 22.50% of the outstanding shares have been sold short.

Short Interest	19.36M
Short Previous Month	18.82M
Short % of Shares Out	22.50%
Short % of Float	25.16%
Short Ratio (days to cover)	10.46

Income Statement

In the last 12 months, SNDX had revenue of $23.68 million and -$318.76 million in losses. Loss per share was -$3.72.

Revenue	23.68M
Gross Profit	-218.79M
Operating Income	-339.67M
Pretax Income	-264.08M
Net Income	-318.76M
EBITDA	-339.66M
EBIT	-339.67M
Loss Per Share	-$3.72

Balance Sheet

The company has $582.91 million in cash and $345.74 million in debt, giving a net cash position of $237.17 million or $2.76 per share.

Cash & Cash Equivalents	582.91M
Total Debt	345.74M
Net Cash	237.17M
Net Cash Per Share	$2.76
Equity (Book Value)	288.12M
Book Value Per Share	3.36
Working Capital	499.51M

Cash Flow

Operating Cash Flow	-274.90M
Capital Expenditures	n/a
Free Cash Flow	-274.90M
FCF Per Share	-$3.19

Margins

Gross Margin	n/a
Operating Margin	-1,434.43%
Pretax Margin	-1,346.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.67%
Shareholder Yield	-21.67%
Earnings Yield	-28.50%
FCF Yield	-24.58%

Analyst Forecast

The average price target for SNDX is $36.20, which is 178.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$36.20
Price Target Difference	178.25%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	94.20%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SNDX has an Altman Z-Score of -0.68 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.68
Piotroski F-Score	1